Osaic Holdings
WST icon

Osaic Holdings’s West Pharmaceutical WST Stock Holding History

Osaic Holdings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46M Buy
9,626
+2,047
+27% +$626K ﹤0.01% 1839
2026
Q1 		$1.9M Sell
7,579
-1,312
-15% -$326K ﹤0.01% 2124
2025
Q4 		$2.45M Sell
8,891
-4,436
-33% -$1.21M ﹤0.01% 1919
2025
Q3 		$3.4M Buy
13,327
+866
+7% +$210K ﹤0.01% 1767
2025
Q2 		$2.74M Buy
12,461
+1,647
+15% +$352K ﹤0.01% 1658
2025
Q1 		$2.42M Sell
10,814
-1,338
-11% -$369K 0.01% 1521
2024
Q4 		$3.45M Buy
12,152
+2,323
+24% +$731K 0.01% 1253
2024
Q3 		$2.95M Buy
9,829
+984
+11% +$301K 0.01% 1413
2024
Q2 		$2.91M Buy
8,845
+1,719
+24% +$607K 0.01% 1375
2024
Q1 		$2.82M Sell
7,126
-18,497
-72% -$6.84M 0.01% 1442
2023
Q4 		$9.03M Sell
25,623
-16,287
-39% -$5.76M 0.02% 854
2023
Q3 		$15.7M Buy
41,910
+10,842
+35% +$4.19M 0.02% 642
2023
Q2 		$11.9M Sell
31,068
-517
-2% -$185K 0.02% 680
2023
Q1 		$11M Sell
31,585
-707
-2% -$207K 0.02% 733
2022
Q4 		$7.6M Sell
32,292
-31,199
-49% -$7.39M 0.02% 860
2022
Q3 		$15.6M Buy
63,491
+20,441
+47% +$6.23M 0.04% 475
2022
Q2 		$13M Sell
43,050
-8,980
-17% -$2.92M 0.03% 535
2022
Q1 		$19.8M Buy
52,030
+343
+0.7% +$134K 0.04% 431
2021
Q4 		$24.2M Buy
51,687
+3,400
+7% +$1.46M 0.05% 369
2021
Q3 		$20.5M Buy
48,287
+1,276
+3% +$538K 0.04% 389
2021
Q2 		$16.9M Buy
47,011
+6,293
+15% +$2.08M 0.04% 445
2021
Q1 		$11.5M Buy
40,718
+2,985
+8% +$854K 0.03% 532
2020
Q4 		$10.7M Buy
37,733
+4,611
+14% +$1.29M 0.03% 498
2020
Q3 		$8.92M Buy
33,122
+2,295
+7% +$607K 0.03% 501
2020
Q2 		$7M Buy
30,827
+4,611
+18% +$906K 0.02% 571
2020
Q1 		$4.01M Buy
+26,216
New +$4.04M 0.02% 705

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Osaic Holdings's WST Position: Q2 2026 in Review

Osaic Holdings increased its West Pharmaceutical (WST) stake by 27% in Q2 2026, buying an estimated $626K and bringing the position to 9,626 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Osaic Holdings first reported a position in WST in Q1 2020 and has held it in 26 quarters since. The position peaked at $24.2M in Q4 2021. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Osaic Holdings held 9,626 shares of West Pharmaceutical worth $3.46M as of Q2 2026.
  • Osaic Holdings bought 2,047 West Pharmaceutical shares in Q2 2026, an estimated $626K.
  • West Pharmaceutical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #1839 holding.
  • Osaic Holdings first reported a position in West Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's West Pharmaceutical position peaked at $24.2M in Q4 2021.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.